Director, Member, Executive & Compensation Committee, Chair of Nominating & Governance Committee
(2014 - Present)
Byron has served on the board of Genelux since 2014, serves on the Executive and Compensation committees and chairs the Nominating and Governance Committee. Headquartered in San Diego, California, Genelux Corporation is a leader in oncolytic immunotherapy, utilizing its potent CHOICE™ discovery platform to develop a library of proprietary, oncolytic vaccinia virus-based diagnostic and therapeutic candidates.
